157 related articles for article (PubMed ID: 20175809)
1. Is a picture worth a thousand (forgotten) words?: neuroimaging evidence for the cognitive deficits in 'chemo-fog'/'chemo-brain'.
Raffa RB
J Clin Pharm Ther; 2010 Feb; 35(1):1-9. PubMed ID: 20175809
[TBL] [Abstract][Full Text] [Related]
2. Effects on the visual system might contribute to some of the cognitive deficits of cancer chemotherapy-induced 'chemo-fog'.
Raffa RB; Tallarida RJ
J Clin Pharm Ther; 2010 Jun; 35(3):249-55. PubMed ID: 20831527
[TBL] [Abstract][Full Text] [Related]
3. Is 'chemo-fog'/'chemo-brain' caused by cancer chemotherapy?
Raffa RB; Duong PV; Finney J; Garber DA; Lam LM; Mathew SS; Patel NN; Plaskett KC; Shah M; Jen Weng HF
J Clin Pharm Ther; 2006 Apr; 31(2):129-38. PubMed ID: 16635046
[No Abstract] [Full Text] [Related]
4. Imaging as a means of studying chemotherapy-related cognitive impairment.
Raffa RB
Adv Exp Med Biol; 2010; 678():70-6. PubMed ID: 20738008
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of chemotherapy-induced cognitive disorders: neuropsychological, pathophysiological, and neuroimaging perspectives.
Saykin AJ; Ahles TA; McDonald BC
Semin Clin Neuropsychiatry; 2003 Oct; 8(4):201-16. PubMed ID: 14613048
[TBL] [Abstract][Full Text] [Related]
6. Cancer 'survivor-care': II. Disruption of prefrontal brain activation top-down control of working memory capacity as possible mechanism for chemo-fog/brain (chemotherapy-associated cognitive impairment).
Raffa RB
J Clin Pharm Ther; 2013 Aug; 38(4):265-8. PubMed ID: 23656522
[TBL] [Abstract][Full Text] [Related]
7. A proposed mechanism for chemotherapy-related cognitive impairment ('chemo-fog').
Raffa RB
J Clin Pharm Ther; 2011 Jun; 36(3):257-9. PubMed ID: 21545608
[TBL] [Abstract][Full Text] [Related]
8. Chemo brain - a psychotropic drug phenomenon?
Jackson GE
Med Hypotheses; 2008; 70(3):572-7. PubMed ID: 17686588
[TBL] [Abstract][Full Text] [Related]
9. The (mis)classification of chemo-fog--methodological inconsistencies in the investigation of cognitive impairment after chemotherapy.
Shilling V; Jenkins V; Trapala IS
Breast Cancer Res Treat; 2006 Jan; 95(2):125-9. PubMed ID: 16261398
[TBL] [Abstract][Full Text] [Related]
10. Chemo brain (chemo fog) as a potential side effect of doxorubicin administration: role of cytokine-induced, oxidative/nitrosative stress in cognitive dysfunction.
Aluise CD; Sultana R; Tangpong J; Vore M; St Clair D; Moscow JA; Butterfield DA
Adv Exp Med Biol; 2010; 678():147-56. PubMed ID: 20738017
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy and Cognitive Function in Breast Cancer Patients: The So-Called Chemo Brain.
Hermelink K
J Natl Cancer Inst Monogr; 2015 May; 2015(51):67-9. PubMed ID: 26063891
[TBL] [Abstract][Full Text] [Related]
12. Lost in the fog: understanding "chemo brain".
Hafner DL
Nursing; 2009 Aug; 39(8):42-5. PubMed ID: 19633502
[No Abstract] [Full Text] [Related]
13. The phenomenon of chemo brain.
Staat K; Segatore M
Clin J Oncol Nurs; 2005 Dec; 9(6):713-21. PubMed ID: 16381547
[TBL] [Abstract][Full Text] [Related]
14. Late effects of adjuvant chemotherapy for adult onset non-CNS cancer; cognitive impairment, brain structure and risk of dementia.
Koppelmans V; Breteler MM; Boogerd W; Seynaeve C; Schagen SB
Crit Rev Oncol Hematol; 2013 Oct; 88(1):87-101. PubMed ID: 23768778
[TBL] [Abstract][Full Text] [Related]
15. Integrating functional near-infrared spectroscopy in the characterization, assessment, and monitoring of cancer and treatment-related neurocognitive dysfunction.
Jean-Pierre P
Neuroimage; 2014 Jan; 85 Pt 1():408-14. PubMed ID: 23831530
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer treatment and cognitive functioning: current status and future challenges in assessment.
Castellon SA; Silverman DH; Ganz PA
Breast Cancer Res Treat; 2005 Aug; 92(3):199-206. PubMed ID: 16155790
[No Abstract] [Full Text] [Related]
17. Opening up the window into "chemobrain": a neuroimaging review.
Scherling CS; Smith A
Sensors (Basel); 2013 Mar; 13(3):3169-203. PubMed ID: 23467031
[TBL] [Abstract][Full Text] [Related]
18. Cognitive impairment associated with chemotherapy for cancer: report of a workshop.
Tannock IF; Ahles TA; Ganz PA; Van Dam FS
J Clin Oncol; 2004 Jun; 22(11):2233-9. PubMed ID: 15169812
[TBL] [Abstract][Full Text] [Related]
19. The influence of priming and pre-existing knowledge of chemotherapy-associated cognitive complaints on the reporting of such complaints in breast cancer patients.
Schagen SB; Das E; van Dam FS
Psychooncology; 2009 Jun; 18(6):674-8. PubMed ID: 19021129
[TBL] [Abstract][Full Text] [Related]
20. Neural correlates of chemotherapy-related cognitive impairment.
Kaiser J; Bledowski C; Dietrich J
Cortex; 2014 May; 54():33-50. PubMed ID: 24632463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
